APOE and Alzheimer disease: Using this path framework, and genetic variations in sex, TREM2 and APOE-ε4 as instrumental variables we can infer how different biological processes influence the AD cascade leading to increases in discrete stages of tau pathology (i.e., medial temporal tau and neocortical tau).